BIOMAT Database Logo BIOMAT Database Logo

[Experience in using visken in ischemic heart disease and arterial hypertension]. 1977

F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
January 1990, Sovetskaia meditsina,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Effectiveness of tobanum and visken in ischemic heart disease with extrasystole].
January 1989, Sovetskaia meditsina,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Visken in the treatment of arterial hypertension].
December 1975, Polski tygodnik lekarski (Warsaw, Poland : 1960),
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.
April 2000, Hypertension (Dallas, Tex. : 1979),
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Arterial hypertension and ischemic heart disease: clinico-echocardiographic aspects].
January 2003, Klinicheskaia meditsina,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Experience in the realization of diagnostic and treatment algorithms in ischemic heart disease and arterial hypertension].
July 1997, Voenno-meditsinskii zhurnal,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
Arterial Hypertension and Ischemic Heart Disease: Comparison in Epidemiological Studies.
June 1963, Canadian Medical Association journal,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Hemodynamic features in patients with ischemic heart disease and arterial hypertension].
January 1994, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Epidemiologic approach in studying arteriosclerosis, ischemic heart disease and arterial hypertension].
February 1971, Kardiologiia,
F I Komarov, and I S Kun, and V M Markova, and I L Mytareva, and V I Ostrovskaia
[Ischemic heart disease and arterial hypertension in Yakutsk (clinico-epidemiologic study)].
March 1977, Kardiologiia,
Copied contents to your clipboard!